A Multi-Pathway Approach to Neuroprotection
While preclinical results are promising, clinical data remain limited. Two early-phase human studies have examined GLP1RAs in substance use contexts,…
While preclinical results are promising, clinical data remain limited. Two early-phase human studies have examined GLP1RAs in substance use contexts,…